CSIMarket
 

Tao Synergies Inc   (NASDAQ: TAOX)

Tao Synergies Inc 's

Competitiveness




 

TAOX Sales vs. its Competitors Q1 2026



Comparing the current results to its competitors, Tao Synergies Inc reported Revenue increase in the 1 quarter 2026 by 0 % year on year.
The revenue growth was below Tao Synergies Inc 's competitors' average revenue growth of 20.37 %, achieved in the same quarter.

List of TAOX Competitors

With a net margin of 910.2 % Tao Synergies Inc achieved higher profitability than its competitors.

More on TAOX Profitability Comparisons



Revenue Growth Comparisons




Net Income Comparison


Tao Synergies Inc Net Income in the 1 quarter 2026 grew year on year by 818.64%, faster than the Tao Synergies Inc 's competitors average income growth of 194.6 %

<<  TAOX Stock Performance Comparisons



*Market share is calculated based on total revenue.





Publicly Traded Peers of Tao Synergies Inc




Azitra Inc
Share Performance



-35.13%
This Year



Azitra Inc
Profile

Azitra Inc is a company that operates on a business model focused on developing and commercializing microbiome-based therapeutics for various skin conditions. It aims to use the potential of the human skin microbiome to develop innovative and effective treatments.

More about Azitra Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 2.809 mill. $ - mill. $ -11.814 mill.


Allarity Therapeutics Inc
Share Performance



+23.68%
This Year



Allarity Therapeutics Inc
Profile

Allarity Therapeutics Inc is a biotechnology company that leverages its unique drug response profiling platform to develop personalized cancer treatments. They use AI algorithms to match patients with the most effective therapies by analyzing their individual molecular profiles.

More about Allarity Therapeutics Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 22.434 mill. $ - mill. $ -12.334 mill.


Aixcrypto Holdings Inc
Share Performance



-3.38%
30 Days



Aixcrypto Holdings Inc
Profile

AIxCrypto Holdings develops software focused on tokenizing real-world assets and deploying embodied artificial intelligence.

More about Aixcrypto Holdings Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 15.641 mill. $ - mill. $ -13.172 mill.


Damora Therapeutics Inc
Share Performance



+29.15%
This Year



Damora Therapeutics Inc
Profile

The company is a preclinical stage biotechnology firm focused on developing product candidates for various diseases.

More about Damora Therapeutics Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 1,722.279 mill. $ - mill. $ -62.116 mill.


Protagenic Therapeutics Inc new
Share Performance



+29.21%
Over The Past 5 Days



Protagenic Therapeutics Inc new
Profile

Protagenic Therapeutics Inc has developed a novel business model focused on the discovery and development of novel therapeutics targeting the PGRMC1 receptor, which plays a crucial role in various diseases. By leveraging their proprietary technology and partnerships, the company aims to advance the development of innovative drugs that can effectively treat a range of conditions influenced by the PGRMC1 receptor.

More about Protagenic Therapeutics Inc new's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 2.082 mill. $ - mill. $ 5.462 mill.

55 more competitors available

Sign in to see all competitors

Sources: Tao Synergies Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Tao Synergies Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.